Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.
Vasiliki PelekanouDaniel E Carvajal-HausdorfMehmet AltanBrad WassermanCristobal Carvajal-HausdorfHallie WimberlyJason BrownDonald LanninLajos PusztaiDavid L RimmPublished in: Breast cancer research : BCR (2017)
Increase in stromal TILs in residual cancer compared to pretreatment tissue is associated with improved recurrence-free survival. Despite a trend for increasing TIL counts, PD-L1 expression decreased in residual disease compared to pretreatment samples.